Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Vitamin D and Reduced Tumor Necrosis Factor Alpha

Research synthesisModerate evidenceMixed effect size5 studies · 3 beneficial · 2 neutral · 0 harmful

Across 5 studies, 3 reported beneficial effects (small to moderate magnitude) of vitamin D supplementation on reducing tumor necrosis factor alpha (TNF-α) levels, while 2 found neutral effects. The beneficial findings come from systematic reviews and meta-analyses in populations including depression patients, overweight/obese individuals, and those with chronic pruritus. Doses ranged from 1000 to 5000 IU/day where reported, but most studies did not specify dose or duration.

  • Studied populations: depression patients, overweight/obese adults, individuals with chronic pruritus

Caveats: Two studies found neutral effects in overweight/obese children and older adults with vitamin D deficiency, suggesting benefit may depend on population and baseline status. One beneficial study combined vitamin D with magnesium, so the effect cannot be solely attributed to vitamin D. Effect sizes were small to moderate, and clinical significance remains uncertain. Most studies did not report supplementation duration, limiting interpretability.

Generated Jul 12, 2026
Doses used in studies
  • IU/day: 1,000–5,000 (median 3,000, IQR 2,0004,000) 2 studies
Time to effect
Median: 8 weeks · IQR 8 weeks8 weeks · Range 8 weeks8 weeks — Reported in 1 of 5 studies
5 of 5 papers
Back to top